Breast Cancer

Cancer Research

Scientists at the Morgridge Institute are working to understand—and stop—deadly cancers. Our scientists and collaborators are creating new imaging techniques, harnessing T-cell immunotherapies, and building powerful tools that can diagnose cancer earlier and develop safer, more effective treatments and therapies.

Cancer Research at the Morgridge Institute

Areas of Expertise

  • Biomedical imaging & microscopy
  • T-cell immunotherapies
  • Tumor microenvironments
  • Viral-induced cancers

Cancer-specific research

  • Pancreatic cancer
  • Breast cancer
  • Cervical cancer
  • Neuroendocrine cancer
  • Blood cancer

The basic biology of cancer is still largely a mystery. That’s why fundamental, early-stage research is essential to helping clinicians and cancer researchers study, diagnose, and treat cancers.

At the Morgridge Institute, scientists across biology are working to better understand and stop cancer. Our teams in biomedical imaging, virology, bioinformatics, and metabolism are working with cancer researchers at the UW Carbone Cancer Center, the National Institutes for Health and Stand Up to Cancer to drive new advances.

In biomedical imaging, scientists are developing advanced tools to diagnose cancer earlier and test new drugs and therapies faster. They are applying novel imaging techniques, such as fluorescence imaging, to study some of the deadliest cancers, like pancreatic cancer which kills more than 90 percent of people within the first five years of diagnosis.

These techniques are opening new pathways to test drug responses in lab-grown cancer samples, and study slow-growing neuroendocrine tumors. Non-invasive imaging is also an important testing ground to understand how other cell types in the body, like T-Cells and macrophages, could slow, stop, or even speed up cancer in some patients.

Morgridge experts in virology, metabolism, and bioinformatics are also contributing new knowledge about the unique environments that tumors create inside the body, and how some viruses, like Human Papillomavirus (HPV) and Hepatitis C, can lead to cervical and liver cancers respectively.

But it’s not just scientists in the lab who are helping fight cancer. Computer scientists and bioinformatics experts are important partners in cancer research. Experts here are making new ‘big data’ tools that help cancer researchers screen, test, and review therapeutics against the huge, growing body of data, research and information

In the News

Morgridge scientists take on new research challenges

Bernstein wraps postdoc,  joins cancer research startup

Bernstein wraps postdoc, joins cancer research startup

After years of building tools for bioinformatics research, Morgridge Postdoctoral Fellow Matt Bernstein takes his skills to industrial cancer research.

Optical imaging highlights metabolic interactions that make pancreatic tumor cells grow

Optical imaging highlights metabolic interactions that make pancreatic tumor cells grow

An advanced biomedical imaging technique reveals how cancer cells can hijack the metabolic activity of certain non-cancer cells in the pancreas to fuel tumor growth.

Navigating the unCHARTed: web tool explores public sequencing data for cancer research

Navigating the unCHARTed: web tool explores public sequencing data for cancer research

Morgridge Postdoctoral Fellow Matthew Bernstein developed a web tool to explore public RNAseq datasets to facilitate analysis for cancer researchers.

The (cell) medium is the message: A new tool for studying cell biology in a dish

The (cell) medium is the message: A new tool for studying cell biology in a dish

Morgridge investigator Jason Cantor is partnering with Thermo Fisher Scientific to give biologists a new medium to study human cells in their most natural state.

Imaging technique sheds light on a notoriously slow-growing cancer

Imaging technique sheds light on a notoriously slow-growing cancer

Neuroendocrine cancers grow so slowly they often evade detection before it's too late. By mimicking that slow growth in the lab, the Melissa Skala Lab hopes to speed up the creation of more effective treatments.

Redox imaging allows measurement of drug responses in lab-grown cancer samples

Redox imaging allows measurement of drug responses in lab-grown cancer samples

Scientists have developed a nondestructive way of measuring drug treatment responses in lab-grown cancer samples.

Help Scientists

When you give, you’re helping scientists improve human health. Morgridge scientists are fighting deadly diseases and contributing new research to stop COVID-19, cancer, HIV/AIDS, and other disorders.

Current Projects

Here is a sampling of some cancer-related research initiatives at Morgridge.

  • Skala Lab
    The majority of our work is focused on cancer imaging, using photonics-based technologies. The most exciting ongoing project is in cancer immunology, including imaging new therapies in mouse models and immune cell engineering. We also are developing robust quality control technologies for T cell manufacturing, for use in immunotherapy. Another major focus is on developing cancer organoids for high-throughput testing of wide range of potential chemotherapies. We work closely with oncologists to collect fresh patient biopsies that are maintained in 3D culture (tumor organoids), which are used to screen response to multiple treatment options for each patient. In work sponsored by Stand Up to Cancer, we are seeking ways to identify metabolic vulnerabilities of cancer.
  • Coon Lab
    Cancer investigators rely on myriad technologies to gain insight into mechanisms of cancer progression and successful therapeutic approaches. Critical to their investigations is the analysis of the important biological actors — the molecules like proteins and metabolites that are at the heart of all cellular functions. Our cutting-edge mass spectrometry resources have become critical for many aspects of cancer research across UW-Madison, including understanding the aberrant cellular function of cancer cells, discovering critical cancer progression biomarkers, and guiding therapies for cancer treatment. We founded the Cancer Metabolomics and Proteomics Resource (CAMP) to generate large-scale quantitative data for these molecules in support of researchers at the UW-Madison Carbone Cancer Center. We have collaborated with more than two dozen UW-Madison cancer investigators in the past five years.
  • Gitter Lab
    My computational biology team is using biological networks and pathways to interpret multiple types of cancer-related “omic” data: genomic, transcriptomic, proteomic, etc. The first project is with Morgridge Virology Investigator Paul Ahlquist and several UW-Madison collaborators. We’re using pathway analysis algorithms to come up with a better consensus understanding of what cellular changes are driving cancer when individual measurements (such as DNA changes or gene expression changes) disagree. Our collaborators are working on head and neck cancer. A second project has similar goals but is using more modern computational tools and will be capable of reasoning with more data types. We also have an early drug screening project with a Wisconsin Institute for Research collaborator, hoping to identify new chemicals to inhibit an important cancer-related protein.